Frontotemporal dementia (FTD) is fatal. There is no cure and no treatment that slows the underlying brain degeneration. Average survival from symptom onset is roughly 8 to 9 years, though the range varies widely depending on the subtype, from as few as 3 years to more than 11.
How Long People Survive
Survival statistics for FTD depend on whether you measure from when symptoms first appear or from when a diagnosis is made. That distinction matters because FTD is frequently misdiagnosed early on, often as a psychiatric condition. On average, about three years pass between the first symptoms and a correct diagnosis. So when studies report a median survival of 3 to 7 years “from diagnosis,” the disease has usually been progressing for several years already.
A 2025 study in the Journal of Neurology, Neurosurgery & Psychiatry found a median survival of 6.9 years from diagnosis for FTD, the shortest of any dementia subtype studied. One quarter of FTD patients in that study died within just 3.2 years of diagnosis. Measured from symptom onset, overall survival across FTD subtypes averages around 8 to 9 years, though some subtypes push that number higher or lower.
Survival Varies Significantly by Subtype
FTD is not one disease but a family of related conditions, and the specific subtype has a major influence on how quickly it progresses.
- Behavioral variant FTD (bvFTD): The most common form, marked by personality changes and impulsive behavior. Median survival from diagnosis is about 3.5 years, making it one of the faster-progressing subtypes.
- Semantic dementia: Affects the ability to understand words and recognize objects. This subtype progresses more slowly, with survival from symptom onset averaging around 11 years.
- Progressive nonfluent aphasia: Gradually destroys the ability to produce speech. Average survival is roughly 8.5 years from onset.
- FTD with motor neuron disease (ALS): The most aggressive form. When FTD occurs alongside ALS, median survival drops to about 2.5 to 3 years. One study found that the addition of ALS cut median survival from presentation to just 1.4 years.
Primary progressive aphasia subtypes (semantic dementia and progressive nonfluent aphasia) generally allow more time than behavioral variant FTD. A population-based study found that people with primary progressive aphasia survived a median of 73 months (about 6 years) from diagnosis, compared to 43 months (about 3.5 years) for behavioral variant FTD.
How FTD Compares to Alzheimer’s
FTD progresses to death faster than Alzheimer’s disease. From symptom onset, median survival for the behavioral variant of FTD is about 8.7 years, compared to 11.8 years for Alzheimer’s. From the time a person first sees a specialist, that gap is even starker: 3 years for behavioral variant FTD versus 5.7 years for Alzheimer’s.
FTD also tends to strike earlier, often between ages 45 and 65, meaning it cuts into working and parenting years in a way Alzheimer’s typically does not. The 2025 study found that FTD patients had the highest all-cause mortality risk of any early-onset dementia group, with a death rate nearly 14 times higher than that of matched controls without dementia. That risk remained high even after excluding the most aggressive FTD-ALS cases.
Genetics and Disease Speed
About 30 to 40 percent of FTD cases have a strong family history, and three gene mutations account for most inherited cases. These mutations influence how fast the disease moves. A 2019 study in The Lancet found that people with MAPT mutations survived an average of 9.3 years from symptom onset. Those with GRN mutations averaged 7.1 years, and those with C9orf72 mutations, the most common genetic cause, averaged 6.4 years. C9orf72 mutations are also the ones most strongly linked to developing motor neuron disease alongside FTD, which helps explain the shorter survival.
What Happens in the Final Stages
FTD is primarily known for its effects on personality, behavior, and language, but in the later stages it increasingly attacks the body. People develop slow, rigid movements similar to Parkinson’s disease. Swallowing becomes difficult and eventually dangerous, because food or liquid can enter the lungs. Bladder and bowel control are lost. Some people lose the ability to speak entirely, progressing from a handful of words per day to complete silence. Eventually, the person can no longer walk, sit up independently, or hold their head up.
This physical decline is what ultimately leads to death. Pneumonia, often caused by food or saliva entering the lungs due to swallowing problems, is one of the most common causes of death. General failure to thrive, where the body simply cannot maintain basic functions, is the other leading cause. Infections and injuries from falls also contribute, particularly in the middle stages when a person may still be mobile but lacks the judgment to avoid hazards.
What Late-Stage Care Looks Like
As FTD enters its final phase, the focus of care shifts entirely to comfort. Hospice eligibility for dementia patients is generally based on reaching a stage where speech is limited to a few words or less per day, the person can no longer walk or sit independently, and at least one complicating condition like recurring infections or significant weight loss is present. Many people with late-stage FTD meet these criteria well before their families realize hospice is an option.
The progression from early behavioral or language symptoms to this level of disability typically spans several years, but the final decline can be relatively rapid. Families often describe a long, slow middle period followed by a sharper drop in the last year or two. Because FTD strikes younger people, caregivers are frequently spouses still raising children or managing careers, which makes early planning for power of attorney, finances, and long-term care especially important.